Strong Q1 FY27: consolidated revenue up 164%, PAT up 93% YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin CompressionResults View source PDF Explain this filing

FCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.6%Reaction day

₹41.85

prior close

₹43.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-6.1% vs market

Specialty Chemicals peers, median of 92sector-0.0%-5.6% vs sector

On the reaction day the stock moved 6.1 pts less than Nifty Microcap 250 and 5.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-5.5

15m

-5.9

30m

-8.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.6+0.4-6.1-0.0-5.6

Next day

-3.2+1.8-5.0+1.4-4.6

-3.0+0.5-3.4+0.5-3.5

-6.5+0.9-7.4+0.9-7.4

-9.6+0.3-9.9-0.7-8.9

-5.9+1.4-7.3+0.2-6.1

-8.3+3.2-11.5+2.0-10.2

15d

+3.7+5.4-1.7+3.1+0.6

+18.3+6.4+11.9+2.2+16.1

+34.5+6.3+28.1+2.6+31.8

+13.8-3.6+17.4-7.0+20.8

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 92Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fineotex Chemical's Q1 FY27 consolidated results show strong growth. Total income rose to Rs. 38,672 lakhs from Rs. 14,622 lakhs YoY (up 164.48%). Operational EBITDA climbed to Rs. 5,914 lakhs from Rs. 2,520 lakhs (up about 135%). PAT grew to Rs. 4,821 lakhs from Rs. 2,503 lakhs (up 92.61%). Volume grew 131% YoY and ROIC stood at 33%. Standalone revenue declined to Rs. 8,515 lakhs from Rs. 9,826 lakhs though PAT edged up. Board recommended a final dividend of Rs. 0.05 per share for FY26. Auditors gave an unqualified limited review report.

Likely market impact

Strong consolidated growth, mainly from subsidiaries, should boost sentiment. However, EBITDA and PAT margins compressed, and standalone business remains weak.